Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus

Table 2 Multivariate analysis of risk factors associated with scarring alopecia

Risk factors	OR (95%CI)	p value
Smoking	1.853 (0.985~3.488)	0.056
SCLICC/ACR-DI (exclude chronic scarring alopecia)	1.409 (1.207~1.646)	< 0.001***
Anti-Sm	1.374 (1.034~1.825)	0.029*
Anti-rRNP	0.808 (0.590~1.108)	0.186
Anti-RNP	1.007 (0.744~1.362)	0.964
Mucocutaneous	2.062 (1.536~2.767)	< 0.001***
Renal	0.714 (0.529~0.964)	0.028*
Cardio-respiratory	0.347 (0.123~0.970)	0.044*
Glucocorticoid	1.196 (0.800~1.789)	0.383
Immunosuppressants^a	0.675 (0.505~0.901)	0.008**

SLICC/ACR-DI Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index, ANA Antinuclear antibody, anti-Sm anti-Smith, anti-rRNP anti-ribosomal P protein, anti-RNP anti-ribonucleoprotein
*p < 0.05; **p < 0.01; ***p < 0.001
^aImmunosuppressants included cyclophosphamide, mycophenolate mofetil, azathioprine, cyclosporine, tacrolimus

ISSN: 1478-6362